IP Library › Granted Patent US 9,951,104
Granted Patent B2
US 9,951,104 · App. 14/370,815 · Granted Apr 24, 2018

Peptides and methods of using same

Inventors: Soren Mogelsvang (Herndon, VA); Cohava Gelber (Nokesville, VA)
Assignee: Serpin Pharma, LLC
C07K7/08C07K14/8125A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,951,104
App. No.
14/370,815
Granted
Apr 24, 2018
Kind
B2
Abstract

We describe peptides and their uses for the treatment of autoimmune, inflammatory and metabolic diseases.

Claims (9)

1. A composition comprising a peptide, wherein the peptide consists of the amino acid sequence of VKFNKPFVFLMIEQNTK (SEQ ID NO: 1).

2. The composition of claim 1 , further comprising at least one second peptide or protein.

3. The composition of claim 2 , wherein the at least one second peptide or protein is an epitope tag or a half-life extender or both.

4. The composition of claim 1 , further comprising a pharmaceutically acceptable carrier.

5. The composition of claim 4 , wherein the pharmaceutically acceptable carrier is an injectable carrier.

6. The composition of claim 5 , wherein the injectable carrier is an intravenous carrier.

7. A composition comprising a peptide consisting of the amino acid sequence of VKFNKPFVFLMIEQNTK (SEQ ID NO: 1) fused to the amino acid sequence of at least one second peptide or protein, wherein the second peptide or protein is an epitope tag or a half-life extender or both.

8. The composition of claim 7 , wherein the at least one second peptide or protein is the epitope tag.

9. The composition of claim 7 , wherein the at least one second peptide or protein is the half-life extender.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2014
From: MOGELSVANG, SOREN; GELBER, COHAVA
To: SERPIN PHARMA, LLC
Reel/Frame 033600/0346 →
Continuity (3)
Provisional Application 61584517 · Jan 9, 2012
Provisional Application 61699571 · Sep 11, 2012
Related Publication 20140378372A1 · Dec 25, 2014